Published online before print July 22, 2004, doi: 10.1161/01.RES.0000139956.42923.4A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 2, 2004
Revised on July 12, 2004
Accepted on July 12, 2004
Vascular Endothelial Growth Factor Activation of Sterol Regulatory Element Binding Protein. A Potential Role in Angiogenesis
Rui-Hai Zhou ;
From the Division of Biomedical Sciences (R.-H.Z., T.-S.L.,Y.Z., J.S.) and Department of Cell Biology and Neurosciences (M.Y., M.M-G.), University of California, Riverside, Riverside, Calif.
* To whom correspondence should be addressed. E-mail: john.shyy{at}ucr.edu.
By stimulating the migration and proliferation of endothelial cells (ECs), vascular endothelial growth factor (VEGF) is a potent angiogenic factor. However, the molecular mechanism involved in the VEGF-induced angiogenesis remains elusive. We hypothesized that sterol regulatory element binding proteins (SREBPs), transcription factors governing cellular lipid homeostasis, play an important role in regulating angiogenesis in response to VEGF. VEGF activated SREBP1 and SREBP2 in ECs, as demonstrated by the increased SREBPs, their cleavage products, and the upregulation of the targeted genes. VEGF-induced SREBP activation depended on SREBP cleavage-activating protein (SCAP), because knocking down SCAP by RNA interference (RNAi) inhibited SREBP activation in response to VEGF. SREBP activation was also blocked by 25-hydroxycholesterol (25-HC). To verify the functional implication of SREBPs in VEGF-induced angiogenesis, we tested the role of SREBPs in EC migration and proliferation. SCAP RNAi or 25-HC inhibited VEGF-induced pseudopodia extension and migration of ECs. Both treatments inhibited VEGF-induced EC proliferation, with cell growth arrested at the G0/G1 phase and a concomitant decrease of the S phase. Blocking the PI3K-Akt pathway inhibited the VEGF-activated SREBPs, demonstrating that PI3K-Akt regulates SREBPs. Consistent with our in vitro data, SREBP1 was detected in newly developed microvasculatures in a rabbit skin partial-thickness wound-healing model. SREBP inhibition also markedly suppressed VEGF-induced angiogenesis in chick embryos. In summary, this study identifies SREBPs as the key molecules in regulating angiogenesis in response to VEGF.
Key words: SREBP • migration • proliferation • angiogenesis • endothelial cells
This article has been cited by other articles:
 |
|
 |
|
  A. Zimman, K. P. Mouillesseaux, T. Le, N. M. Gharavi, A. Ryvkin, T. G. Graeber, T. T. Chen, A. D. Watson, and J. A. Berliner Vascular Endothelial Growth Factor Receptor 2 Plays a Role in the Activation of Aortic Endothelial Cells by Oxidized Phospholipids Arterioscler Thromb Vasc Biol, February 1, 2007; 27(2): 332 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yao, R.-H. Zhou, M. Petreaca, L. Zheng, J. Shyy, and M. Martins-Green Activation of sterol regulatory element-binding proteins (SREBPs) is critical in IL-8-induced angiogenesis J. Leukoc. Biol., September 1, 2006; 80(3): 608 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hamik, B. Wang, and M. K. Jain Transcriptional Regulators of Angiogenesis Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 1936 - 1947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Du, I. Kristiana, J. Wong, and A. J. Brown Involvement of Akt in ER-to-Golgi Transport of SCAP/SREBP: A Link between a Key Cell Proliferative Pathway and Membrane Synthesis Mol. Biol. Cell, June 1, 2006; 17(6): 2735 - 2745. [Abstract] [Full Text] [PDF]
|
|